Literature DB >> 24943550

Developing and testing a mobile application programme to support self-management in patients with stable angina: a feasibility study protocol.

Wenru Wang1, Sally Chan2, Hong-Gu He1.   

Abstract

This study aims to develop and test the feasibility of a 12-week Mobile Application Programme (M.A.P.) to support self-management in cardiac patients with stable angina. A Mobile Application Programme will be developed by the study team. A pilot randomized controlled trial will be adopted to examine the feasibility and potential effectiveness of the M.A.P.. A convenience sample of 40 stable angina patients recruited from the National University Heart Centre will be randomly assigned either to the 12-week M.A.P. intervention group or the control group. Data will be collected at baseline, at the 4th and 12th week of the programme. At the end of the intervention period, a process evaluation will be conducted to further assess the acceptability, usability, strengths and weaknesses of the M.A.P. intervention based on the participants' perspectives. All quantitative data obtained will be analysed using IBM SPSS 21.0, while content analysis will be used for qualitative datasets.

Entities:  

Mesh:

Year:  2014        PMID: 24943550

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  3 in total

1.  A recommended guideline for the development of mHealth Apps.

Authors:  Ioannis A Chatzipavlou; Sofia A Christoforidou; Maro Vlachopoulou
Journal:  Mhealth       Date:  2016-05-18

2.  Development of a Mobile-Based Self-care Application for Patients with Breast Cancer-Related Lymphedema in Iran.

Authors:  Maryam Ahmadi; Seyedeh Nafiseh Shahrokhi; Morteza Khavaninzadeh; Jahanpour Alipour
Journal:  Appl Clin Inform       Date:  2022-10-05       Impact factor: 2.762

Review 3.  Exercise-based cardiac rehabilitation for adults with stable angina.

Authors:  Linda Long; Lindsey Anderson; Alice M Dewhirst; Jingzhou He; Charlene Bridges; Manish Gandhi; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2018-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.